Cover Image
市場調查報告書

合成生物學市場(合成DNA,合成遺傳基因,合成細胞,XNA,底盤生物,DNA合成,寡核苷酸合成):全球產業分析,規模,市場佔有率,成長,趨勢,及預測

Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019

出版商 Transparency Market Research 商品編碼 299349
出版日期 內容資訊 英文 143 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
合成生物學市場(合成DNA,合成遺傳基因,合成細胞,XNA,底盤生物,DNA合成,寡核苷酸合成):全球產業分析,規模,市場佔有率,成長,趨勢,及預測 Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
出版日期: 2014年04月08日 內容資訊: 英文 143 pages
簡介

合成生物學的定義是為製造藉由傳統生物學要素再生的新人工生物體,而合成人工或天然構成要素,在生命科學領域扮演重要的角色。由於合成生物學上技術的進步而促進了科學研究,相信也更進一步促進了合成生物學市場。

本報告提供合成生物學市場相關分析,彙整2013∼2019年的市場收益預測,各產品,各技術趨勢,進入的主要企業簡介等資料,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 推動市場的要素
    • 藥物和疫苗的改良需求
    • 分子生物學的進步
    • 合成生物學研究上政府團體和大學的獎勵和參與計劃
    • 人口增加是否會造成基因重組作物需求增加
  • 阻礙市場的要素
    • 倫理的問題
  • 市場機會
    • 闡明代謝途徑和合成生物學這個概念的初期性質
  • 波特五力分析
  • 市場魅力度分析:各地區

第4章 各產品市場

  • 簡介
  • 核心產品
    • 各類型市場收益
    • 合成DNA
    • 合成遺傳基因
    • 合成細胞
    • XNA
    • 底盤生物
  • 開發可能的產品
    • 各類型市場收益
    • DNA合成
    • 寡核苷酸合成

第5章 各技術市場

  • 簡介
  • 基因工程
  • DNA定序
  • 生物資訊學
  • 生物學的因素與整合系統

第6章 各用途市場

  • 簡介
  • 化學
  • 醫療
  • 農業
  • 其他

第7章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第8章 競爭環境

第9章 建議

第10章 企業簡介

圖表

目錄

Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products.

Synthetic biology, by technologies segment is divided into genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Application segment of synthetic biology market includes healthcare, chemicals, agriculture and others. This report covers participation of different organizations of the U.S. and the U.K. for the development of synthetic biology field. In addition, it explains various technological advancements taking place in each of these segments. The report includes market estimations of the global synthetic biology market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global synthetic biology market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the synthetic biology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.

Some of the key market players of the global synthetic biology market include Agrivida, Inc., Biosearch Technologies, Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporation and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global synthetic biology market is segmented into the following categories:

Synthetic Biology Market, by Products

  • Core Products
    • Synthetic DNA
    • Synthetic Genes
    • Synthetic Cells
    • XNA (Xeno Nucleic Acid)
    • Chasis Organisms
  • Enabling Products
    • DNA Synthesis
    • Oligonucleotide Synthesis

Synthetic Biology Market, by Technologies

  • Genome Engineering
  • DNA Sequencing
  • Bioinformatics
  • Biological Components and Integrated Systems

Synthetic Biology Market, by Applications

  • Healthcare
  • Chemicals (Including Bio-Fuels)
  • Agriculture
  • Others (Biosecurity, R&D, Energy and Environment)

Synthetic Biology Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
    • 2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million)
  • 2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview

  • 3.1 Introduction
  • 3.2 Market Drivers
    • 3.2.1 Drivers
      • 3.2.1.1 Rising demand for improved drugs and vaccines
      • 3.2.1.2 Advancement in molecular biology
      • 3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research
      • 3.2.1.4 Increasing demand of genetically modified crops due to rising population
  • 3.3 Market Restraints
    • 3.3.1 Ethical Issues
  • 3.4 Market Opportunities
    • 3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts
  • 3.5 Porter's Five Force Analysis
    • 3.5.1 Bargaining Power of Suppliers
    • 3.5.2 Bargaining Power of Buyers
    • 3.5.3 Threat of Substitutes
    • 3.5.4 Threat of New Entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography

Chapter 4 Global Synthetic Biology Market, by Products

  • 4.1 Introduction
    • 4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 - 2019 (USD Million)
  • 4.2 Core Products
    • 4.2.1 Global Core Products Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.2.2 Synthetic DNA
      • 4.2.2.1 Global Synthetic DNA Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.3 Synthetic Genes
      • 4.2.3.1 Global Synthetic Genes Market Revenue, 2011 - 2019 (USD Million)
    • 4.2.4 Synthetic Cells
      • 4.2.4.1 Global Synthetic Cells Market Revenue, 2013 - 2019 (USD Million)
    • 4.2.5 XNA (Xeno Nucleic Acid)
      • 4.2.5.1 Global XNA Market Revenue, 2014 - 2019 (USD Million)
    • 4.2.6 Chassis Organisms
      • 4.2.6.1 Global Chassis Organisms Market Revenue, 2015 - 2019 (USD Million)
  • 4.3 Enabling Products
    • 4.3.1 Global Enabling Products Market Revenue, by Types, 2011 - 2019 (USD Million)
    • 4.3.2 DNA Synthesis
      • 4.3.2.1 Global DNA Synthesis Market Revenue, 2011 - 2019 (USD Million)
    • 4.3.3 Oligonucleotide Synthesis
      • 4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Synthetic Biology Market, by Technologies

  • 5.1 Introduction
    • 5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 - 2019 (USD Million)
  • 5.2 Genome Engineering
    • 5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 DNA Sequencing
    • 5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 5.4 Bioinformatics
    • 5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 5.5 Biological Components and Integrated Systems
    • 5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 - 2019 (USD Million)

Chapter 6 Global Synthetic Biology Market, by Applications

  • 6.1 Introduction
    • 6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 6.2 Chemicals
    • 6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 - 2019 (USD Million)
    • 6.3 Healthcare
  • 6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 - 2019 (USD Million)
  • 6.4 Agriculture
    • 6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 - 2019 (USD Million)
  • 6.5 Others (Biosecurity, R&D, Energy and Environment)
    • 6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Global Synthetic Biology Market, by Geography

  • 7.1 Introduction
    • 7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 7.2 North America
    • 7.2.1 North America Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 7.4 Asia-Pacific
    • 7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • 7.5 Rest of the World (RoW)
    • 7.5.1 RoW Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Heat Map Analysis for Key Market Players
    • 8.1.1 Amyris, Inc.
    • 8.1.2 DuPont, Inc.
    • 8.1.3 Royal DSM
    • 8.1.4 Evolva Holding
    • 8.1.5 Life Technologies Corporation
  • 8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013

Chapter 9 Recommendations

  • 9.1 Market Strategy for Success
    • 9.1.1 Focus on investing in research and development activities
    • 9.1.2 Strategic alliance, mergers and acquisitions
  • 9.2 Barriers to be Considered
    • 9.2.1 Ethical issues associated with synthetic biology products

Chapter 10 Company Profiles

  • 10.1 Agrivida, Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Product Portfolio
    • 10.1.4 Business Strategies
    • 10.1.5 Recent Developments
  • 10.2 Amyris, Inc.
    • 10.2.1 Company Profile
    • 10.2.2 Financial Overview
    • 10.2.3 Product Portfolio
    • 10.2.4 Business Strategies
    • 10.2.5 Recent Developments
  • 10.3 Algenol Biofuels, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Product Portfolio
    • 10.3.4 Business Strategies
    • 10.3.5 Recent Developments
  • 10.4 ATG:biosynthetics GmbH
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Product Portfolio
    • 10.4.4 Business Strategies
    • 10.4.5 Recent Developments
  • 10.5 Bayer AG
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Product Portfolio
    • 10.5.4 Business Strategies
    • 10.5.5 Recent Developments
  • 10.6 Bristol-Myers Squibb
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Product Portfolio
    • 10.6.4 Business Strategies
    • 10.6.5 Recent Developments
  • 10.7 BIONEER CORPORATION
    • 10.7.1 Company Overview
    • 10.7.2 Product Portfolio
    • 10.7.3 Business Strategies
    • 10.7.4 Recent Developments
  • 10.8 Biosearch Technologies, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Product Portfolio
    • 10.8.4 Business Strategies
    • 10.8.5 Recent Developments
  • 10.9 CBC Comprehensive Biomarker Center GmbH
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Product Portfolio
    • 10.9.4 Business Strategies
    • 10.9.5 Recent Developments
  • 10.10 Cobalt Technologies
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Product Portfolio
    • 10.10.4 Business Strategies
    • 10.10.5 Recent Developments
  • 10.11 DuPont, Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Financial Overview
    • 10.11.3 Product Portfolio
    • 10.11.4 Business Strategies
    • 10.11.5 Recent Developments
  • 10.12 Evolva SA
    • 10.12.1 Company Overview
    • 10.12.2 Financial Overview
    • 10.12.3 Product Portfolio
    • 10.12.4 Business Strategies
    • 10.12.5 Recent Developments
  • 10.13 Exxon Mobil Corporation
    • 10.13.1 Company Overview
    • 10.13.2 Financial Overview
    • 10.13.3 Product Portfolio
    • 10.13.4 Business Strategies
    • 10.13.5 Recent Developments
  • 10.14 Ginkgo Bioworks
    • 10.14.1 Company Overview
    • 10.14.2 Financial Overview
    • 10.14.3 Product Portfolio
    • 10.14.4 Business Strategies
    • 10.14.5 Recent Developments
  • 10.15 GeneWorks Pty Ltd.
    • 10.15.1 Company Overview
    • 10.15.2 Financial Overview
    • 10.15.3 Product Portfolio
    • 10.15.4 Business Strategies
    • 10.15.5 Recent Developments
  • 10.16 Genomatica, Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Financial Overview
    • 10.16.3 Product Portfolio
    • 10.16.4 Business Strategies
    • 10.16.5 Recent Developments
  • 10.17 GeneScript Corporation
    • 10.17.1 Company Overview
    • 10.17.2 Financial Overview
    • 10.17.3 Product Portfolio
    • 10.17.4 Business Strategies
    • 10.17.5 Recent Developments
  • 10.18 Gevo, Inc.
    • 10.18.1 Company Overview
    • 10.18.2 Financial Overview
    • 10.18.3 Product Portfolio
    • 10.18.4 Business Strategies
    • 10.18.5 Recent Developments
  • 10.19 Green Biologics Limited
    • 10.19.1 Company Overview
    • 10.19.2 Financial Overview
    • 10.19.3 Product Portfolio
    • 10.19.4 Business Strategies
    • 10.19.5 Recent Developments
  • 10.20 New England Biolabs, Inc.
    • 10.20.1 Company Overview
    • 10.20.2 Financial Overview
    • 10.20.3 Product Portfolio
    • 10.20.4 Business Strategies
    • 10.20.5 Recent Developments
  • 10.21 OriGene Technologies, Inc.
    • 10.21.1 Company Overview
    • 10.21.2 Financial Overview
    • 10.21.3 Product Portfolio
    • 10.21.4 Business Strategies
    • 10.21.5 Recent Developments
  • 10.22 REG Life Sciences, LLC
    • 10.22.1 Company Overview
    • 10.22.2 Financial Overview
    • 10.22.3 Product Portfolio
    • 10.22.4 Business Strategies
    • 10.22.5 Recent Developments
  • 10.23 Royal DSM
    • 10.23.1 Company Overview
    • 10.23.2 Financial Overview
    • 10.23.3 Product Portfolio
    • 10.23.4 Business Strategies
    • 10.23.5 Recent Developments
  • 10.24 Thermo Fisher Scientific, Inc.
    • 10.24.1 Company Overview
    • 10.24.2 Financial Overview
    • 10.24.3 Product Portfolio
    • 10.24.4 Business Strategies
    • 10.24.5 Recent Developments

List of Figures

  • FIG. 1 Synthetic Biology Market Segmentation
  • FIG. 2 Global Synthetic Biology Market, by Technologies, 2012 (USD Million)
  • FIG. 3 Comparative Analysis: Global Synthetic Biology Market, by Geography, 2012 and 2019 (Value %)
  • FIG. 4 Porter's Five Forces Analysis: Global Synthetic Biology Market
  • FIG. 5 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
  • FIG. 6 Global Synthetic DNA Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 7 Global Synthetic Genes Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 8 Global Synthetic Cells Market Revenue, 2013 - 2019 (USD Million)
  • FIG. 9 Global XNA Market Revenue, 2014 - 2019 (USD Million)
  • FIG. 10 Global Chassis Organisms Market Revenue, 2015 - 2019 (USD Million)
  • FIG. 11 Global DNA Synthesis Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12 Global Oligonucleotide Synthesis Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Biological Components and Integrated Systems in Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17 Global Synthetic Biology in Chemicals Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18 Global Synthetic Biology in Healthcare Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19 Global Synthetic Biology in Agriculture Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20 Global Synthetic Biology in Other Applications Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21 North America Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22 Europe Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23 Asia-Pacific Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24 RoW Synthetic Biology Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
  • FIG. 26 Amyris, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 27 Bayer AG: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28 Bristol-Myers Squibb: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 29 DuPont, Inc.: Annual Revenue, 2010- 2012 (USD Million)
  • FIG. 30 Evolva SA: Annual Sales, 2010 - 2012 (USD Million), 1 CHF = 1.13 USD
  • FIG. 31 Exxon Mobil Corporation: Annual Sales, 2010 - 2012 (USD Billion)
  • FIG. 32 Gevo, Inc.: Annual Sales, 2010 - 2012 (USD Million)
  • FIG. 33 Renewable Energy Group, Inc.: Annual Sales, 2011 - 2013 (USD Million)
  • FIG. 34 Royal DSM: Annual Revenue, 2010- 2012 (USD Million)
  • FIG. 35 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
  • TABLE 3 Global Synthetic Biology Market Revenue, by Products, 2011 - 2019 (USD Million)
  • TABLE 4 Global Core Products Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 5 Global Enabling Products Market Revenue, by Types, 2011 - 2019 (USD Million)
  • TABLE 6 Global Synthetic Biology Market Revenue, by Technologies, 2011 - 2019 (USD Million)
  • TABLE 7 Global Synthetic Biology Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • TABLE 8 U.S. Bio-fuels Pipeline Products, by Organizations
  • TABLE 9 Developed Drugs and Vaccines Utilizing the Concept of Synthetic Biology
  • TABLE 10 Global Synthetic Biology Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • TABLE 11 List of Organizations and their Synthetic Biology Products and Applications
Back to Top